Form D · Other Investment Fund

EP Life Sciences L.P.

New York, NY · CIK 0001744892

Offering snapshot reported May 14, 2026 · SEC filing

Reported sold
$508M
Indefinite offering
Investors reported
170
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 1, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$254M$508MJun 28, 2018Jun 17, 2019: $130,145,182.00Jun 8, 2020: $108,402,391.00Jun 8, 2021: $176,805,781.00May 31, 2022: $228,784,669.00May 15, 2023: $418,696,509.00May 14, 2024: $448,763,010.00May 14, 2025: $471,050,887.00May 14, 2026: $507,821,582.00May 14, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$471,050,887 → $507,821,582
  • Reported investors223 → 170

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 14, 2026Amendment$507,821,582$36,770,695vs May 14, 2025170SEC filing
May 14, 2025Amendment$471,050,887$22,287,877vs May 14, 2024223SEC filing
May 14, 2024Amendment$448,763,010$30,066,501vs May 15, 2023213SEC filing
May 15, 2023Amendment$418,696,509$189,911,840vs May 31, 2022205SEC filing
May 31, 2022Amendment$228,784,669$51,978,888vs Jun 8, 2021149SEC filing
Jun 8, 2021Amendment$176,805,781$68,403,390vs Jun 8, 2020127SEC filing
Jun 8, 2020Amendment$108,402,391-$21,742,791vs Jun 17, 2019106SEC filing
Jun 17, 2019Amendment$130,145,182No comparison88SEC filing
Jun 28, 2018InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-315695

Source: Form D, filed May 14, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

EP LIFE SCIENCES L.P.

Investment adviser: EHRENKRANZ PARTNERS L.P.

Gross asset value
$543M
Beneficial owners
79
ADV minimum commitment
$500K

Reported in Form ADV on Jun 8, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SEI GLOBAL SERVICES INC OAKS, Pennsylvania, United States Investor statements: No (provided to no investors) Related to adviser: No
Auditor ERNST & YOUNG LLP NEW YORK, New York, United States
Custodian BMO HARRIS BANK N.A. CHICAGO, Illinois, United States Related to adviser: No
Custodian PERSHING ADVISOR SOLUTIONS LLC JERSEY CITY, New Jersey, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

ERNST & YOUNG LLP
PCAOB 42

PERSHING ADVISOR SOLUTIONS LLC
SEC 8-47425

Filing source

Form ADV 2103114 · Jun 8, 2026 · Schedule D 7.B.(1), fund 805-5699609636

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kurt Dudas Executive
Sanford B. Ehrenkranz Executive
John B Ehrenkranz Executive
Joel S. Ehrenkranz Executive
Kabir Kapoor Executive
Patrick Jc Shaw Executive
Andrew Sommers Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
375 Park Avenue
New York, NY, 10152